Maayan Konigstein - Concepedia

Author

Maayan Konigstein

Also Known As

Konigstein Maayan, M Konigstein, M. Konigstein, M., Konigstein, Maayan Konigstein, Mayaan Konigstein, Mitchel B. Lustre, Periprocedural Bleeding, Yolayfi Peralta

150

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Tel Aviv University Tel Aviv Sourasky Medical Center Cardiovascular Research Foundation New York Hospital Queens NewYork–Presbyterian Hospital

About

Maayan Konigstein is an author at Tel Aviv University specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	671
2	Public Health	9	9	250
3	Engineering	1	1	32
4	Health Sciences	1	1	32
5	Anesthesia	1	1	29

Maayan Konigstein

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Tricuspid regurgitation and long-term clinical outcomes Ehud Chorin, Zach Rozenbaum, Yan Topilsky, European Heart Journal - Cardiovascular Imaging	2019	257
Outcomes Among Diabetic Patients Undergoing Percutaneous Coronary Intervention With Contemporary Drug-Eluting Stents Maayan Konigstein, Ori Ben‐Yehuda, Pieter C. Smits, JACC: Cardiovascular Interventions Percutaneous Coronary InterventionDiabetes ManagementCardiovascular DiseaseHealth PolicyDiabetes	2018	60
Safety and efficacy of the reducer: A multi-center clinical registry - REDUCE study Francesco Giannini, Luca Baldetti, Maayan Konigstein, International Journal of Cardiology Disease ManagementPreventive MedicineHealth PolicyClinical EffectivenessMulti-center Clinical Registry	2018	58
The Obesity Paradox in Patients Undergoing Transcatheter Aortic Valve Implantation Maayan Konigstein, Ofer Havakuk, Yaron Arbel, Clinical Cardiology	2015	55
Periprocedural Bleeding, Acute Kidney Injury, and Long-term Mortality After Transcatheter Aortic Valve Implantation Maayan Konigstein, Eyal Ben–Assa, Shmuel Banai, Canadian Journal of Cardiology Cardiovascular DiseaseMedicineVascular SurgeryValve DiseaseLong-term Mortality	2014	55
Transcatheter treatment for refractory angina with the coronary sinus Reducer Maayan Konigstein, Nathalie Meyten, Stefan Verheye, EuroIntervention	2014	55
Comparison of the Edwards SAPIEN S3 Versus Medtronic Evolut-R Devices for Transcatheter Aortic Valve Implantation Jeremy Ben‐Shoshan, Maayan Konigstein, David Zahler, The American Journal of Cardiology Device TherapyVascular SurgeryValve DiseaseMechanical Circulatory SupportSurgery	2016	55
Drug-induced Brugada syndrome: Clinical characteristics and risk factors Maayan Konigstein, Raphaël Rosso, Guy Topaz, Heart Rhythm Drug-induced Brugada SyndromePharmacologyClinical PharmacologyPharmacotherapyMedicine	2016	52
Coronary Sinus Reducer implantation improves symptoms, ischaemia and physical capacity in patients with refractory angina unsuitable for myocardial revascularisation: a single-centre experience Maayan Konigstein, Samuel Bazan, Miri Revivo, EuroIntervention	2018	50
Incidence and predictors of target lesion failure in patients undergoing contemporary DES implantation—Individual patient data pooled analysis from 6 randomized controlled trials Maayan Konigstein, Mahesh V. Madhavan, Ori Ben‐Yehuda, American Heart Journal Target Lesion FailureClinical TrialsOutcomes ResearchSurgeryMedicine	2019	48

Page 1